Domperidone for nausea and vomiting: lack of efficacy in children; reminder of contraindications in adults and adolescents

Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg.

Letters and drug alerts sent to healthcare professionals in November 2019

Letters were sent about ranibizumab and Emerade adrenaline auto-injectors

Posted on the UK MHRA website on 16 December 2019